Post-Op Pain Control for Prophylactic Intramedullary Nailing.
Status: | Recruiting |
---|---|
Conditions: | Cancer, Chronic Pain, Post-Surgical Pain, Blood Cancer, Lymphoma, Hematology |
Therapuetic Areas: | Hematology, Musculoskeletal, Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 2/23/2019 |
Start Date: | February 20, 2019 |
End Date: | October 1, 2020 |
Contact: | David Greenberg, MD |
Email: | david.greenberg@health.slu.edu |
Phone: | 3145778904 |
Nationally, the opioid crisis has become a major epidemic with increasing mortality rates
each year. Orthopedic surgeons routinely prescribe narcotics instead of NSAIDs for post-op
pain control because of risk of delayed healing and nonunion due to NSAID use. Orthopedic
oncology, however, has a unique subset of patients that undergo prophylactic placement of
intramedullary femoral nails. Because no fracture is present, these patients do not rely on
inflammatory healing factors, allowing for post-op NSAID use. This study sets out to
determine the effect of post-op toradol use in addition to opioids compared to solely opioids
in patients undergoing prophylactic nailing of the femur.
each year. Orthopedic surgeons routinely prescribe narcotics instead of NSAIDs for post-op
pain control because of risk of delayed healing and nonunion due to NSAID use. Orthopedic
oncology, however, has a unique subset of patients that undergo prophylactic placement of
intramedullary femoral nails. Because no fracture is present, these patients do not rely on
inflammatory healing factors, allowing for post-op NSAID use. This study sets out to
determine the effect of post-op toradol use in addition to opioids compared to solely opioids
in patients undergoing prophylactic nailing of the femur.
Nationally, the opioid crisis has become a major epidemic with increasing mortality rates
each year. Orthopedic surgeons routinely prescribe narcotics instead of NSAIDs for post-op
pain control because of risk of delayed healing and nonunion due to NSAID use. Orthopedic
oncology, however, has a unique subset of patients that undergo prophylactic placement of
intramedullary femoral nails, often due to bone metastases that increase risk for future
fractures. Because no fracture is present, these patients do not rely on inflammatory healing
factors, allowing for post-op NSAID use.
Recent literature has demonstrated the efficacy of multi-modal pain management in treating
post-op pain [1]. Currently, patients that undergo prophylactic intramedullary femur nail
placement at SLU are often treated with both narcotics and toradol, as long as they can
tolerate NSAIDs. However, the effect of toradol in addition to narcotics has not been
determined. This study sets out to determine the effect of post-op toradol use in addition to
opioids compared to solely opioids in patients undergoing prophylactic nailing of the femur.
each year. Orthopedic surgeons routinely prescribe narcotics instead of NSAIDs for post-op
pain control because of risk of delayed healing and nonunion due to NSAID use. Orthopedic
oncology, however, has a unique subset of patients that undergo prophylactic placement of
intramedullary femoral nails, often due to bone metastases that increase risk for future
fractures. Because no fracture is present, these patients do not rely on inflammatory healing
factors, allowing for post-op NSAID use.
Recent literature has demonstrated the efficacy of multi-modal pain management in treating
post-op pain [1]. Currently, patients that undergo prophylactic intramedullary femur nail
placement at SLU are often treated with both narcotics and toradol, as long as they can
tolerate NSAIDs. However, the effect of toradol in addition to narcotics has not been
determined. This study sets out to determine the effect of post-op toradol use in addition to
opioids compared to solely opioids in patients undergoing prophylactic nailing of the femur.
Inclusion Criteria:
1. Femoral Shaft or Neck bone lesion
2. 18 years old or greater
3. Plan to undergo prophylactic intramedullary nailing of one or both femurs
Exclusion Criteria:
1. Concurrent pathologic fracture
2. History of advanced renal impairment
3. History of Peptic Ulcer Disease
4. History of NSAID or aspirin allergy
5. Concurrent chemotherapy regimen that prevents NSAID use
6. History of liver disease that precludes use of toradol
7. History of heart failure or cardiovascular disease
8. Pregnancy
9. History of opioid allergy that prevents used of opioids
10. Patients with coagulation disorders or those who require concomitant use of
anticoagulant or anti- platelet therapy during the treatment phase of the study.
11. Patients with acetaminophen allergies.
12. Current use of the medication probenecid
13. Current use of the medication Pentoxifylline
14. History of aspirin induced asthma.
15. History of coronary artery bypass graft
16. Known history of opioid dependence, abuse, or addiction.
We found this trial at
1
site
Click here to add this to my saved trials